# Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease

> **NCT01712711** · PHASE2 · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 40 (actual)

## Conditions studied

- Non-alcoholic Fatty Liver Disease

## Interventions

- **DRUG:** H.pylori eradication

## Key facts

- **NCT ID:** NCT01712711
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-02
- **Final completion:** 2013-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01712711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01712711, "Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01712711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*